# A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)

> **NCT07389109** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **PPM Services S.A.** · enrollment: 400 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** N-Acetyl-GED-0507-34-LEVO gel 5%

## Key facts

- **NCT ID:** NCT07389109
- **Lead sponsor:** PPM Services S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-05
- **Primary completion:** 2026-04
- **Final completion:** 2026-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07389109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07389109, "A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07389109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*